Kevin E. Weddington

Array ( [id] => 9355385 [patent_doc_number] => 08673918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/682343 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7415 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12682343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568083 [patent_doc_number] => 20100234362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'USE OF DIAZOXIDE FOR SUPPRESSING THE PLASMA INSULIN LEVEL IN A MAMMAL' [patent_app_type] => utility [patent_app_number] => 12/734002 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6918 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234362.pdf [firstpage_image] =>[orig_patent_app_number] => 12734002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361558 [patent_doc_number] => 20090036352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'DRUG DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES COMPRISING RAPAMYCIN AND DERIVATIVES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/242980 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8648 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036352.pdf [firstpage_image] =>[orig_patent_app_number] => 12242980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7728673 [patent_doc_number] => 08101213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Xanthohumol compositions and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/209681 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 8776 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101213.pdf [firstpage_image] =>[orig_patent_app_number] => 12209681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350090 [patent_doc_number] => 20090005451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/208877 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10332 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005451.pdf [firstpage_image] =>[orig_patent_app_number] => 12208877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361663 [patent_doc_number] => 20090036457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Utilities of olefin derivatives' [patent_app_type] => utility [patent_app_number] => 12/230993 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20775 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036457.pdf [firstpage_image] =>[orig_patent_app_number] => 12230993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8006199 [patent_doc_number] => 08084500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Method of using catalpic acid to treat dyslipidemia' [patent_app_type] => utility [patent_app_number] => 12/228800 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11226 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084500.pdf [firstpage_image] =>[orig_patent_app_number] => 12228800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509153 [patent_doc_number] => 20090082360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Use of tyrosine kinase inhibitors for treating CNS disorders' [patent_app_type] => utility [patent_app_number] => 12/191149 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6446 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082360.pdf [firstpage_image] =>[orig_patent_app_number] => 12191149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355564 [patent_doc_number] => 20090186908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy' [patent_app_type] => utility [patent_app_number] => 12/222534 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3612 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186908.pdf [firstpage_image] =>[orig_patent_app_number] => 12222534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322915 [patent_doc_number] => 20090060905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Use of 15-Lipoxygenase Inhibitors for Treating Obesity' [patent_app_type] => utility [patent_app_number] => 12/182881 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060905.pdf [firstpage_image] =>[orig_patent_app_number] => 12182881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779503 [patent_doc_number] => 20080287501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'THERAPEUTIC USES OF AN INSULIN SECRETION ENHANCER' [patent_app_type] => utility [patent_app_number] => 12/180689 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5869 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287501.pdf [firstpage_image] =>[orig_patent_app_number] => 12180689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564737 [patent_doc_number] => 20090137590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'N-LINKED HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/171209 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 41561 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137590.pdf [firstpage_image] =>[orig_patent_app_number] => 12171209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290958 [patent_doc_number] => 20090023688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Microbicidal composition' [patent_app_type] => utility [patent_app_number] => 12/217680 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9342 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023688.pdf [firstpage_image] =>[orig_patent_app_number] => 12217680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4580200 [patent_doc_number] => 07834058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Method of using catalpic acid to treat hyperinsulinemia' [patent_app_type] => utility [patent_app_number] => 12/167375 [patent_app_country] => US [patent_app_date] => 2008-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8062 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834058.pdf [firstpage_image] =>[orig_patent_app_number] => 12167375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860493 [patent_doc_number] => 20080269343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'GALENIC FORMULATIONS OF ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/164794 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9534 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269343.pdf [firstpage_image] =>[orig_patent_app_number] => 12164794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564745 [patent_doc_number] => 20090137598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'METHOD OF TREATING METABOLIC DISORDERS AND DEPRESSION WITH DOPAMINE RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/144617 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7473 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137598.pdf [firstpage_image] =>[orig_patent_app_number] => 12144617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681844 [patent_doc_number] => 20080248070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'HDL-Boosting Combination Therapy Complexes' [patent_app_type] => utility [patent_app_number] => 12/143217 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10946 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248070.pdf [firstpage_image] =>[orig_patent_app_number] => 12143217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664184 [patent_doc_number] => 20080255091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'COMPOUNDS TO TREAT AMYLOIDOSIS AND PREVENT DEATH OF BETA-CELLS IN TYPE 2 DIABETES MELLITUS' [patent_app_type] => utility [patent_app_number] => 12/143691 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11165 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255091.pdf [firstpage_image] =>[orig_patent_app_number] => 12143691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624497 [patent_doc_number] => 08003795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Compounds and compositions for reducing lipid levels' [patent_app_type] => utility [patent_app_number] => 12/143664 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 39249 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003795.pdf [firstpage_image] =>[orig_patent_app_number] => 12143664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522100 [patent_doc_number] => 20090030081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'USE OF LR-90 AND LR-102 TO OVERCOME INSULIN RESISTANCE' [patent_app_type] => utility [patent_app_number] => 12/139822 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11801 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030081.pdf [firstpage_image] =>[orig_patent_app_number] => 12139822 [rel_patent_id] =>[rel_patent_doc_number] =>)